VEGFA and neoplasm: Thrombectomy, tyrosine kinase inhibitors, vena cava inferior, neoplasm staging, vascular endothelial growth factor, tumor grade, and bland thrombus emboli, have emerged as the central areas of research interest in this field in the most recent studies.